UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach

Neurological sciences, 2022-03, Vol.43 (3), p.1499-1502

2022

Volltextzugriff (PDF)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

Frontiers in immunology, 2019-03, Vol.10, p.376-376

2019

Volltextzugriff (PDF)

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

The New England journal of medicine, 2001-07, Vol.345 (3), p.165-169

2001

Volltextzugriff (PDF)

Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy

Mediterranean journal of hematology and infectious diseases, 2016-10, Vol.8 (1), p.e2016050-e2016050

2016

Volltextzugriff (PDF)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study

Frontiers in medicine, 2021-02, Vol.8, p.621590-621590

2021

Volltextzugriff (PDF)

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen

Frontiers in medicine, 2020-12, Vol.7, p.587345

2020

Volltextzugriff (PDF)

Systemic lupus erythematosus and thrombosis

Thrombosis journal, 2015-04, Vol.13 (1), p.16-16, Article 16

2015

Volltextzugriff (PDF)

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

JAMA internal medicine, 2015-09, Vol.175 (9), p.1474

2015

Volltextzugriff (PDF)

Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et al

Arthritis & rheumatology (Hoboken, N.J.), 2020-10, Vol.72 (10), p.1774-1776

2020

Volltextzugriff (PDF)

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients

Rheumatology (Oxford, England), 2021-03, Vol.60 (3), p.1106-1113

2021

Volltextzugriff (PDF)

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol

Clinical and experimental rheumatology, 2023-03, Vol.41 (3), p.597

2023

Volltextzugriff (PDF)

Prevalence of the Antiphospholipid Antibodies in Young Adults with Ischemic Stroke

Blood, 2019-11, Vol.134 (Supplement_1), p.4952-4952

2019

Volltextzugriff (PDF)

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)

Blood, 2022-11, Vol.140 (Supplement 1), p.6945-6948

2022

Volltextzugriff (PDF)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

The Lancet. Rheumatology, 2021-12, Vol.3 (12), p.e832-e832

2021

Volltextzugriff (PDF)

Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

American journal of hematology, 2023-08, Vol.98 (8), p.E204-E208

2023

Volltextzugriff (PDF)

Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

Mediterranean journal of hematology and infectious diseases, 2016-10, Vol.8, p.2016050

2016

Volltextzugriff (PDF)

retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

Annals of hematology, 2010-07, Vol.89 (7), p.691-699

2010

Volltextzugriff (PDF)

8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study

Inflammation research, 2012-08, Vol.61 (8), p.809-816

2012

Volltextzugriff (PDF)

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients

Internal and emergency medicine, 2009-02, Vol.4 (1), p.61-62

2009

Volltextzugriff (PDF)

Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery

Thrombosis and haemostasis, 1999-11, Vol.82 (5), p.1399-1402

1999

Volltextzugriff (PDF)

Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study

Internal and emergency medicine, 2009-12, Vol.4 (6), p.491-495

2009

Volltextzugriff (PDF)

Lupus anticoagulant : Performance of a new, fully automated commercial screening and confirmation assay

Clinical chemistry (Baltimore, Md.), 2005-06, Vol.51 (6), p.1031-1033

2005

Volltextzugriff (PDF)

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen

Frontiers in medicine, 2020, Vol.7, p.587345-587345

2020

Volltextzugriff (PDF)

Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy

Mediterranean journal of hematology and infectious diseases, 2016, Vol.8 (1), p.e2016050-e2016050

2016

Volltextzugriff (PDF)

Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease

Haematologica (Roma), 1997-07, Vol.82 (4), p.420

1997

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)
Berichte
(2)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen

Systemic lupus erythematosus and thrombosis

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et al

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol

Prevalence of the Antiphospholipid Antibodies in Young Adults with Ischemic Stroke

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients

Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery

Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study

Lupus anticoagulant : Performance of a new, fully automated commercial screening and confirmation assay

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen

Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy

Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease

Suchergebnisse filtern